Cargando…
Bovine TB in New Zealand – journey from epidemic towards eradication
Bovine tuberculosis (TB), caused by Mycobacterium bovis, has a unique and complex ecology in New Zealand. Unlike elsewhere in the world, the disease is maintained in Australian brushtail possums (Trichosurus vulpecula) and so they are considered a vector for disease transmission in New Zealand. Poss...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466679/ https://www.ncbi.nlm.nih.gov/pubmed/37649127 http://dx.doi.org/10.1186/s13620-023-00248-7 |
_version_ | 1785098940670017536 |
---|---|
author | Sinclair, Jane New, Dallas Neill, Mark |
author_facet | Sinclair, Jane New, Dallas Neill, Mark |
author_sort | Sinclair, Jane |
collection | PubMed |
description | Bovine tuberculosis (TB), caused by Mycobacterium bovis, has a unique and complex ecology in New Zealand. Unlike elsewhere in the world, the disease is maintained in Australian brushtail possums (Trichosurus vulpecula) and so they are considered a vector for disease transmission in New Zealand. Possums were initially introduced to the country in the 1800’s to establish a fur industry but later becoming a recognized pest to native New Zealand flora and fauna. The TB programme in New Zealand (TBFree NZ Ltd) is managed by a not-for-profit limited company partnership between primary industries and government (OSPRI – Operational Solutions for Primary Industries) that uses the basic tenets of disease management, movement control and vector control to eliminate TB in farmed cattle and deer. Evidence of resounding success in the TB control programme resulted in the 2016 decision to pursue full biological eradication of disease from the country by 2055, with the interim objectives of TB freedom in livestock herds by 2026 and TB freedom in possums by 2040. The programme has progressed from an all-time high of 1698 infected herds in 1995 to the lowest recorded point prevalence of 18 infected herds in May 2022. Enhancements that have contributed to the success of the programme include testing with gamma-interferon release assay (Bovigam™) of animals in infected herds that are negative to the skin test (parallel interpretation), culturing pooled lymph nodes from animals without visible lesions, increased testing of herds post-clearance and introduction of post-movement testing of high-risk animals. |
format | Online Article Text |
id | pubmed-10466679 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-104666792023-08-31 Bovine TB in New Zealand – journey from epidemic towards eradication Sinclair, Jane New, Dallas Neill, Mark Ir Vet J Case Study Bovine tuberculosis (TB), caused by Mycobacterium bovis, has a unique and complex ecology in New Zealand. Unlike elsewhere in the world, the disease is maintained in Australian brushtail possums (Trichosurus vulpecula) and so they are considered a vector for disease transmission in New Zealand. Possums were initially introduced to the country in the 1800’s to establish a fur industry but later becoming a recognized pest to native New Zealand flora and fauna. The TB programme in New Zealand (TBFree NZ Ltd) is managed by a not-for-profit limited company partnership between primary industries and government (OSPRI – Operational Solutions for Primary Industries) that uses the basic tenets of disease management, movement control and vector control to eliminate TB in farmed cattle and deer. Evidence of resounding success in the TB control programme resulted in the 2016 decision to pursue full biological eradication of disease from the country by 2055, with the interim objectives of TB freedom in livestock herds by 2026 and TB freedom in possums by 2040. The programme has progressed from an all-time high of 1698 infected herds in 1995 to the lowest recorded point prevalence of 18 infected herds in May 2022. Enhancements that have contributed to the success of the programme include testing with gamma-interferon release assay (Bovigam™) of animals in infected herds that are negative to the skin test (parallel interpretation), culturing pooled lymph nodes from animals without visible lesions, increased testing of herds post-clearance and introduction of post-movement testing of high-risk animals. BioMed Central 2023-08-30 /pmc/articles/PMC10466679/ /pubmed/37649127 http://dx.doi.org/10.1186/s13620-023-00248-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Case Study Sinclair, Jane New, Dallas Neill, Mark Bovine TB in New Zealand – journey from epidemic towards eradication |
title | Bovine TB in New Zealand – journey from epidemic towards eradication |
title_full | Bovine TB in New Zealand – journey from epidemic towards eradication |
title_fullStr | Bovine TB in New Zealand – journey from epidemic towards eradication |
title_full_unstemmed | Bovine TB in New Zealand – journey from epidemic towards eradication |
title_short | Bovine TB in New Zealand – journey from epidemic towards eradication |
title_sort | bovine tb in new zealand – journey from epidemic towards eradication |
topic | Case Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466679/ https://www.ncbi.nlm.nih.gov/pubmed/37649127 http://dx.doi.org/10.1186/s13620-023-00248-7 |
work_keys_str_mv | AT sinclairjane bovinetbinnewzealandjourneyfromepidemictowardseradication AT newdallas bovinetbinnewzealandjourneyfromepidemictowardseradication AT neillmark bovinetbinnewzealandjourneyfromepidemictowardseradication |